Trial Profile

A Phase I Clinical Study of BVX-0918A for Late-Stage Ovarian Cancer in Spain

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 06 Dec 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

01 Dec 2022 According to a BioVaxys media release, company has completed the clinical study protocol, and EU clinical development and marketing partner, Procare Health Iberia, has selected a CRO and already begun meeting with prospective Spanish Phase I study investigators
18 May 2022 According to a BioVaxys media release, Hospices Civils de Lyon, France (HCL) has agreed to serve as a clinical study site for this Phase I study of BVX-0918, BioVaxys is preparing to file a Clinical Trial Application with the European Medicines Agency later in 2022.
25 Apr 2022 According to a BioVaxys media release, this study expected to begin later this year.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com